.

Make Better Decisions

  • Identify first generic entrants
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

Deloitte
Mallinckrodt
Fuji
Federal Trade Commission
US Army
Covington
Teva
Novartis
Colorcon
Harvard Business School

Generated: February 18, 2018

DrugPatentWatch Database Preview

Drug Master Files for: methscopolamine

« Back to Dashboard


DMF No. Status Type Submission Date Holder Subject
1809I9/30/1971CENTERCHEM INCMETHSCOPOLAMINE BROMIDE, N.F. XIII
7410AII3/30/1988PHYTEX AUSTRALIA PARTY LTDMETHSCOPOLAMINE BROMIDE
18069III2/8/2005BOEHRINGER INGELHEIM PHARMA GMBH AND CO KGMETHSCOPOLAMINE BROMIDE
18294III4/20/2005BOEHRINGER INGELHEIM PHARMA GMBH AND CO KGMETHSCOPOLAMINE NITRATE
28629AII9/8/2014ALKALOIDS CORPMETHSCOPOLAMINE BROMIDE
29805AII9/24/2015ALCHEM INTERNATIONAL LTDMETHSCOPOLAMINE BROMIDE USP
30962AII9/10/2016VITAL LABORATORIES PVT LTDMETHSCOPOLAMINE BROMIDE
This preview shows a limited number of results
Subscribe for full access, or try a Trial

Export unavailable in trial.
Subscribe for complete access.


Drug Master File Glossary

STATUS OF DMFS

  • A = Active. This means that the DMF was found acceptable for filing, administratively, and is up-to-date.
  • I = Inactive
  • N = Not an assigned number
  • P = DMF Pending Filing Review

TYPES OF DMFs

  • Type I Manufacturing Site, Facilities, Operating Procedures, and Personnel (no longer applicable)
  • Type II Drug Substance, Drug Substance Intermediate, and Material Used in Their Preparation, or Drug Product
  • Type III Packaging Material
  • Type IV Excipient, Colorant, Flavor, Essence, or Material Used in Their Preparation
  • Type V FDA Accepted Reference Information

« Back to Dashboard

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Harvard Business School
QuintilesIMS
US Department of Justice
Baxter
Chubb
Chinese Patent Office
Federal Trade Commission
Dow
Colorcon
Citi

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2018 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions

Follow DrugPatentWatch:

botpot